European journal of clinical nutrition

Multispecies probiotics and their effects on migraines and gut leakiness in a placebo-controlled trial

Updated

Abstract

Migraine intensity scores decreased significantly in both the probiotic and placebo groups (P<0.001).

  • The Migraine Disability Assessment Scale (MIDAS) scores improved for all participants.
  • The Headache Disability Inventory (HDI) score decreased significantly in the probiotic group (P=0.032) and showed a borderline decrease in the placebo group (P=0.053).
  • Probiotic group patients reported a median of 6 migraine days in the first month, compared to 5 days in the placebo group, with no significant difference across the months.
  • A reduction of 2 or more migraine days was observed in 12 out of 31 patients in the probiotic group compared to 7 out of 29 in the placebo group, which was not statistically significant.
  • Probiotic treatment did not significantly alter medication use, intestinal permeability, or inflammation when compared to the placebo.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free